39.21
Xenon Pharmaceuticals Inc (XENE) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
100.00%
-
|
7.50 | - | - | - |
|
17.44%
94.23
|
80.24 | 73.68 | 69.10 | 59.04 |
Benefits Costs and Expenses |
18.32%
85.33
|
72.12 | - | - | - |
Costs And Expenses |
18.32%
85.33
|
72.12 | - | - | - |
Depreciation and Amortization |
4.10%
0.632
|
0.659 | 0.669 | 0.659 | 0.599 |
Operating Income/Loss |
29.55%
-94.23
|
-72.74 | -73.68 | -69.10 | -59.04 |
Nonoperating Income/Loss |
9.60%
8.897
|
8.118 | 10.57 | 10.85 | 11.52 |
Income/Loss From Continuing Operations Before Tax |
32.05%
-85.33
|
-64.62 | -63.11 | -58.26 | -47.52 |
Income Tax Expense/Benefit, Deferred |
85.99%
-0.17
|
-1.213 | -0.322 | -0.333 | 0.403 |
Income Tax Expense/Benefit |
246.60%
-0.626
|
0.427 | -0.32 | -0.333 | 0.412 |
Income/Loss From Continuing Operations After Tax |
30.22%
-84.71
|
-65.05 | -62.79 | -57.92 | -47.93 |
|
30.22%
-84.71
|
-65.05 | -62.79 | -57.92 | -47.93 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.34%
78.95
|
78.69 | 77.93 | 77.67 | 77.59 |
Diluted Average Shares |
0.34%
78.95
|
78.69 | 77.93 | 77.67 | 77.59 |
Basic Earnings Per Share |
28.92%
-1.07
|
-0.83 | -0.81 | -0.75 | -0.62 |
Diluted Earnings Per Share |
28.92%
-1.07
|
-0.83 | -0.81 | -0.75 | -0.62 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):